SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT
LIVE
Serial Number
50087189
Owner
Axsome Therapeutics, Inc.Attorney
Brent A. JohnsonFiling Date
Sep 2, 2026
SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT Trademark
Serial Number: 50087189
SUMMIT STUDYING NMDA AND SIGMA-1 IN SMOKING CESSATION TREATMENT is a trademark filed by
Axsome Therapeutics, Inc.
on September 2, 2026. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
September 2, 2026
Registration Date
Not Registered
Goods & Services
Medicated and pharmaceutical preparations for use in connection with smoking cessation; medications for reducing or eliminating smoking and the urge to smoke.
